BlackRock, Inc. 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Puma Biotechnology, Inc. PBYI |
BlackRock Inc. BLK |
2,779,452 5.600% |
-1,047,771 (-27.38%) |
Filing |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Puma Biotechnology, Inc. PBYI |
BlackRock Inc. BLK |
3,827,223 7.800% |
0 (Unchanged) |
Filing |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Puma Biotechnology, Inc. PBYI |
BlackRock Inc. BLK |
3,827,223 7.800% |
1,924,086 (+101.10%) |
Filing |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Puma Biotechnology, Inc. PBYI |
BlackRock Inc. BLK |
1,903,137 4.200% |
-1,301,100 (-40.61%) |
Filing |
| 2022-02-02 7:11 pm Purchase |
2021-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
BlackRock Inc. BLK |
3,204,237 7.800% |
208,222 (+6.95%) |
Filing |
| 2021-01-29 5:23 pm Purchase |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
BlackRock Inc. BLK |
2,996,015 7.500% |
104,679 (+3.62%) |
Filing |